Ernexa Therapeutics Inc. Deferred Revenue (Non-Current)
Ernexa Therapeutics Inc. (ERNA) had Deferred Revenue (Non-Current) of $298.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2025-03-12
- 2024-06-30: Deferred Revenue, Noncurrent $298.00K.
- 2024-03-31: Deferred Revenue, Noncurrent $345.00K.
- 2023-12-31: Deferred Revenue, Noncurrent $392.00K.
- 2023-09-30: Deferred Revenue, Noncurrent $250.00K.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2024-06-30 | $298.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $345.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $392.00K 10-K · filed 2025-03-12 |
| 2023-09-30 | $250.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $250.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $250.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-14 |
| 2020-12-31 | $2.00K 10-K · filed 2021-03-11 |
| 2020-03-31 | $1.00K 10-Q · filed 2020-05-20 |
| 2019-12-31 | $2.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $13.00K 10-Q · filed 2019-11-01 |
| 2019-06-30 | $17.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $23.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $30.00K 10-K · filed 2020-03-19 |
| 2018-09-30 | $31.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $44.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | $50.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $63.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | $85.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $111.00K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $179.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $219.00K 10-K · filed 2018-03-09 |
| 2016-09-30 | $262.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $279.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $325.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $393.00K 10-K · filed 2017-03-09 |
| 2015-09-30 | $413.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $406.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $412.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $378.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $463.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $412.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $362.00K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $798.00K 10-K · filed 2015-03-27 |
| 2013-09-30 | $248.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $189.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $185.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $188.00K 10-K · filed 2014-03-31 |
| 2012-09-30 | $199.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $198.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $188.00K 10-Q · filed 2012-05-11 |
| 2011-12-31 | $186.00K 10-K · filed 2013-03-29 |
| 2011-09-30 | $173.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $160.00K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $124.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |